Clinical Trials Browser

NETWORK × Inflammatory Breast Neoplasms × pegfilgrastim × Clear all

NCT00066443 2023-08-04

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms